Frontlight ResearchEarly access
Trial site
Piedmont Healthcare, Inc
- 8running trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Idiopathic pulmonary fibrosis3 trials
- Aortic stenosis1 trial
- Atrial fibrillation1 trial
- Colorectal cancer1 trial
- High blood pressure1 trial
- Lung cancer1 trial
- Pancreatic cancer1 trial
- Rheumatoid arthritis1 trial
- Stroke1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 24 trials
- Phase 32 trials
- Status
- Active, not recruiting5 trials
- Recruiting3 trials
- Lead sponsor
- Avalyn Pharma Inc.2 trials
- Endevica Bio1 trial
- Icahn School of Medicine at Mount Sinai1 trial
- Medtronic Cardiovascular1 trial
- Orchestra BioMed, Inc1 trial
- and 2 more
Running trials
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recruiting
Recruiting
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Active, not recruiting
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Active, not recruiting
LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation1 recruiting
- Colorectal cancer1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Pancreatic cancer1 recruiting
- Stroke1 recruiting
Site data: ClinicalTrials.govUpdated 13 Nov 2026